I would expect in the short term BD1 might actually fall as the punters try and get into BD1 by buying up SDX below 6.1 cents and hoping the deal goes through maybe even selling some BD1 to do so. The SP doesn’t worry me short term my SDX average price because I have held it for 3 years on SDX is 9 cents , ouch!!
I wish I had of topped up on the recent CR but was so disillusioned with the Board and management didn’t even though still believe in the science.
Will take awhile for the SP to sort out, BD1 with no SDX liquidity and long term holders like me would never have got SDX without a big offer hence such a premium.
Smart move at the right time for both companies I think.
- Forums
- ASX - By Stock
- SDX
- News: SDX Bard1 Life Sciences And Sienna Cancer Diagnostics Announce Merger
News: SDX Bard1 Life Sciences And Sienna Cancer Diagnostics Announce Merger, page-7
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SDX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online